GSK is paying $300 million to get the rights to a drug they believe could treat lupus.
GSK, a pharmaceutical company, is spending $300 million to buy a special type of drug from Chimagen Biosciences, a company […]
GSK, a pharmaceutical company, is spending $300 million to buy a special type of drug from Chimagen Biosciences, a company […]
Ultra-processed foods (UPFs) are linked to health issues like obesity, diabetes, heart disease, and some cancers. In India, obesity rates
Pfizer recently reported strong earnings for the third quarter, surpassing Wall Street expectations. As a result, the company has increased
The UK government and its drug regulator have issued a warning about the misuse of certain weight-loss medications. These drugs,
AbbVie has agreed to buy Aliada Therapeutics for $1.4 billion. This deal includes Aliada’s main product, ALIA-1758, which is being
A recent trial found that nearly 60% of patients with a rare condition called eosinophilic granulomatosis with polyangiitis (EGPA) went
Pfizer and the American Cancer Society (ACS) have teamed up with actor Patrick Dempsey to spotlight healthcare access issues that
At the Outsourcing in Clinical Trials Conference in New England, the US Customs and Border Protection (CBP) highlighted common legal
Parabilis Medicines, previously known as FogPharma, is a biotech company that has changed its name to better reflect its mission.
MVA-BN, a vaccine for mpox (monkeypox) and smallpox, is sold under the name Jynneos in the US and Imvanex in